Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters

Published:2023-12 Issue: Volume: Page:
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Jennings Angus C.,Rutherford Mark J.,Latimer Nicholas R.,Sweeting Michael J.,Lambert Paul C.

Funder

NIHR Imperial Biomedical Research Centre

AstraZeneca

NIHR Leicester Biomedical Research Centre

Yorkshire Cancer Research

National Institute for Health and Care Research

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference36 articles.

1. Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness;Guyot;Value Health,2011

2. Modeling challenges in cost-effectiveness analysis of first-line immuno-oncology therapies in non-small cell lung cancer: a systematic literature review;Kongnakorn;Pharmacoeconomics,2022

3. Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis;Armoiry;Int J Technol Assess Health Care,2022

4. Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium;Willem;Hum Vaccin Immunother,2018

5. Ocrelizumab for treating primary progressive multiple sclerosis,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP